High CSF transforming growth factor b levels after subarachnoid haemorrhage: Association with chronic communicating hydrocephalus

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 80, Issue 5, 2009, Pages 545-550

  Douglas, M R ^a   Daniel, M ^a   Lagord, C ^a   Akinwunmi, J ^b   Jackowski, A ^c   Cooper, C ^a   Berry, M ^a   Logan, A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; ALBUMINOID; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID DRAINAGE; CHRONIC BRAIN DISEASE; CLINICAL ARTICLE; COMMUNICATING HYDROCEPHALUS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; SUBARACHNOID HEMORRHAGE; CHRONIC DISEASE; HYDROCEPHALUS; MIDDLE AGED;

ADULT; AGED; ALBUMINS; CHRONIC DISEASE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROCEPHALUS; MALE; MIDDLE AGED; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 65449137153     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2008.155671     Document Type: Article

References (40)

1. Linn FH, Rinkel GJ, Algra A, et al. Incidence of subarachnoid haemorrhage: role of region, year, and rate of computed tomography: a meta-analysis. Stroke 1996;27:625-9. (Pubitemid 26114421)
2. Kibler RF, Couch RS, Crompton MR. Hydrocephalus in the adult following spontaneous subarachnoid haemorrhage. Brain 1961;84:45-61.
3. Logan A, Berry M. Transforming growth factor-beta 1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 1993;14:337-42. (Pubitemid 23282163)
4. Bottner M, Krieglstein K, Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 2000;75:2227-40.
5. Lagord C, Berry M, Logan A. Expression of TGFbeta2 but not TGFbeta1 correlates with the deposition of scar tissue in the lesioned spinal cord. Mol Cell Neurosci 2002;20:69-92. (Pubitemid 34634329)
6. Roberts AB, Tian F, Byfield SD, et al. Smad3 is key to TGF-beta-mediated epithelialto-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev 2006;17:19-27. (Pubitemid 43117513)
7. Flood C, Akinwunmi J, Lagord C, et al. Transforming growth factor-beta1 in the cerebrospinal fluid of patients with subarachnoid haemorrhage: titers derived from exogenous and endogenous sources. J Cereb Blood Flow Metab 2001;21:157-62. (Pubitemid 32143977)
8. Krupinski J, Kumar P, Kumar S, et al. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 1996;27:852-7. (Pubitemid 26142515)
9. Assoian RK, Komoriya A, Meyers CA, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:7155-60.
10. Heep A, Stoffel-Wagner B, Bartmann P, et al. Vascular endothelial growth factor and transforming growth factor-beta1 are highly expressed in the cerebrospinal fluid of premature infants with posthemorrhagic hydrocephalus. Pediatr Res 2004;56:768-74. (Pubitemid 39403404)
11. Moinuddin SM, Tada T. Study of cerebrospinal fluid flow dynamics in TGF-beta 1 induced chronic hydrocephalic mice. Neurol Res 2000;22:215-22. (Pubitemid 30180804)
12. Whitelaw A, Christie S, Pople I. Transforming growth factor-beta1: a possible signal molecule for posthemorrhagic hydrocephalus? Pediatr Res 1999;46:576-80. (Pubitemid 29496487)
13. Postlethwaite AE, Keski-Oja J, Moses HL, et al. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta. J Exp Med 1987;165:251-6. (Pubitemid 17223686)
14. Edwards DR, Murphy G, Reynolds JJ, et al. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987;6:1899-904.
15. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987;84:5788-92. (Pubitemid 17130416)
16. Logan A, Frautschy SA, Gonzalez AM, et al. Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury. Brain Res 1992;587:216-25.
17. Crews L, Wyss-Coray T, Masliah E. Insights into the pathogenesis of hydrocephalus from transgenic and experimental animal models. Brain Pathol 2004;14:312-16. (Pubitemid 39095995)
18. Galbreath E, Kim SJ, Park K, et al. Overexpression of TGF-beta 1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 1995;54:339-49.
19. Wyss-Coray T, Feng L, Masliah E, et al. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 1995;147:53-67.
20. Morganti-Kossmann MC, Hans VH, Lenzlinger PM, et al. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 1999;16:617-28. (Pubitemid 29350520)
21. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid haemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9. (Pubitemid 10159923)
22. Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Haemorrhage Grading Scale. J Neurosurg 1988;68:985-6.
23. Wahl SM, Allen JB, McCartney-Francis N, et al. Macrophage-and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991;173:981-91.
24. Unsicker K, Flanders KC, Cissel DS, et al. Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system. Neuroscience 1991;44:613-25.
25. Logan A, Green J, Hunter A, et al. Inhibition of glial scarring in the injured rat brain by a recombinant human monoclonal antibody to transforming growth factor-beta2. Eur J Neurosci 1999;11:2367-74. (Pubitemid 29292331)
26. Logan A, Baird A, Berry M. Decorin attenuates gliotic scar formation in the rat cerebral hemisphere. Exp Neurol 1999;159:504-10. (Pubitemid 29485236)
27. Johnson MD, Gold LI, Moses HL. Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid. Lab Invest 1992;67:360-8.
28. Brown PD, Wakefield LM, Levinson AD, et al. Physicochemical activation of recombinant latent transforming growth factor-beta's 1, 2, and 3. Growth Factors 1990;3:35-43. (Pubitemid 20265013)
29. Kitazawa K, Tada T. Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid haemorrhage. Stroke 1994;25:1400-4. (Pubitemid 24198587)
30. Khalil N, Bereznay O, Sporn M, et al. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989;170:727-37. (Pubitemid 19226660)
31. Wakefield LM, Winokur TS, Hollands RS, et al. Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990;86:1976-84.
32. McCartney-Francis N, Mizel D, Wong H, et al. TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 1990;4:27-35.
33. Grainger DJ, Wakefield L, Bethell HW, et al. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995;1:932-7.
34. Germano A, d'Avella D, Cicciarello R, et al. Blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Neurosurgery 1992;30:882-6.
35. Graff-Radford NR, Torner J, Adams HP Jr, et al. Factors associated with hydrocephalus after subarachnoid haemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 1989;46:744-52. (Pubitemid 19182366)
36. Tapaninaho A, Hernesniemi J, Vapalahti M, et al. Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor. Acta Neurochir (Wien) 1993;123:118-24. (Pubitemid 23271955)
37. Suzuki S, Ishii M, Ottomo M, et al. Changes in the subarachnoid space after experimental subarachnoid haemorrhage in the dog: scanning electron microscopic observation. Acta Neurochir (Wien) 1977;39:1-14. (Pubitemid 8188640)
38. Motohashi O, Suzuki M, Shida N, et al. Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space. Immunhistochemical study. Acta Neurochir (Wien) 1995;136:88-91.
39. Dorai Z, Hynan LS, Kopitnik TA, et al. Factors related to hydrocephalus after aneurysmal subarachnoid haemorrhage. Neurosurgery 2003;52:763-9; discussion 769-71. (Pubitemid 36402863)
40. Dehdashti AR, Rilliet B, Rufenacht DA, et al. Shunt-dependent hydrocephalus after rupture of intracranial aneurysms: a prospective study of the influence of treatment modality. J Neurosurg 2004;101:402-7. (Pubitemid 39100715)